Gary W. Pace is Director at RESMED INC (RMD). They have made 41 open-market trades across 6 companies since 2006, most recently 2026-07-14.
CIK 0001184778
23 open-market purchases totalling $5.4M since 2008, against 18 sales. Across 19 scored buys the stock is up 36.9% at ninety days, and 31.9 points ahead of the S&P over the same stretch.
19 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 37% | 47% | 53% |
| Avg Move | +1.1% | +2.0% | +36.9% |
| Alpha | +1.7% | +0.5% | +31.9% |
| Scored | 19 | 19 | 19 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRDF | BUY | 2026-07-14 | 2026-07-16 | $1.46 | $1000K | -8.9% | +1.6% | +8.8% |
| CRDF | BUY | 2026-06-18 | 2026-06-22 | $1.22 | $37K | -2.7% | -34.4% | +5.0% |
| CRDF | BUY | 2025-07-30 | 2025-07-31 | $2.45 | $711K | -1.2% | -20.7% | -8.9% |
| CRDF | BUY | 2024-12-11 | 2024-12-12 | $2.60 | $940K | +8.9% | -3.6% | +15.3% |
| PCRX | SELL | 2024-03-06 | 2024-03-08 | $30.67 | $4.5M | -3.1% | -8.1% | -6.0% |
| CRDF | BUY | 2023-12-19 | 2023-12-19 | $1.37 | $41K | +10.9% | +5.8% | +274.6% |
| CRDF | BUY | 2023-11-10 | 2023-11-14 | $0.98 | $22K | +14.6% | +30.1% | +76.7% |
| PCRX | SELL | 2023-05-11 | 2023-05-15 | $41.78 | $419K | -5.6% | -8.0% | -12.9% |
| CRDF | BUY | 2022-09-15 | 2022-09-19 | $1.71 | $257K | -11.0% | -13.3% | -27.7% |
| PCRX | SELL | 2022-02-28 | 2022-03-01 | $66.87 | $4.0M | +5.1% | +12.9% | -6.4% |
| CRDF | BUY | 2021-09-21 | 2021-09-22 | $6.75 | $203K | -7.8% | -18.0% | -19.1% |
| CRDF | BUY | 2021-03-23 | 2021-03-24 | $10.23 | $102K | -1.3% | -12.7% | -23.0% |
| CRDF | BUY | 2021-03-18 | 2021-03-19 | $10.55 | $32K | -21.8% | -31.9% | -33.8% |
| CRDF | BUY | 2021-03-04 | 2021-03-04 | $9.27 | $14K | +7.5% | +4.6% | -14.6% |
| CRDF | BUY | 2020-09-16 | 2020-09-17 | $5.70 | $15K | +65.4% | +60.1% | +139.1% |
| CRDF | BUY | 2020-05-11 | 2020-05-13 | $1.34 | $1.2M | +52.2% | +84.3% | +345.5% |
| PCRX | BUY | 2018-11-19 | 2018-11-21 | $46.18 | $208K | +4.3% | -10.3% | -13.8% |
| PCRX | BUY | 2018-11-07 | 2018-11-09 | $51.29 | $205K | -6.1% | -6.9% | -24.7% |
| RMD | SELL | 2018-05-08 | 2018-05-10 | $97.37 | $5.5M | +1.1% | +5.6% | +6.9% |
| RMD | SELL | 2017-06-14 | 2017-06-16 | $76.00 | $1.9M | +0.1% | +0.7% | +4.5% |
| RMD | SELL | 2016-08-19 | 2016-08-22 | $69.93 | $2.5M | -1.2% | -6.1% | -13.9% |
| RMD | SELL | 2016-08-19 | 2016-08-22 | $69.93 | $5.0M | -1.2% | -6.1% | -13.9% |
| RMD | SELL | 2016-03-11 | 2016-03-14 | $60.00 | $2.2M | -5.4% | +2.6% | +1.0% |
| PCRX | BUY | 2015-03-13 | 2015-03-17 | $93.83 | $94K | -18.1% | +0.8% | +0.8% |
| RMD | SELL | 2015-01-26 | 2015-01-28 | $66.77 | $3.2M | +0.3% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.